DDO-5936
Based on 1 publication(s) in Google Scholar
DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98.33%
- CAS. Nr.: 2355377-13-6
- Formel: C25H29N5O4S
- Molecular Weight:495.59
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
HY-10214
SNX-2112 -
HY-15785
PimitespibHSP90α/HSP90β Inhibitor -
HY-145102
NCT-58HSP90 C-terminal Inhibitor -
HY-13313
XL888HSP90 Inhibitor -
HY-10213
SNX-5422 -
HY-13301
MPC-3100HSP Inhibitor -
HY-15205
GanetespibHSP90 Inhibitor -
HY-119046
SNX-0723Hsp90 Inhibitor -
HY-10212
BIIB021HSP90 Inhibitor -
HY-15190
NVP-HSP990Apoptosis Inducer -
HY-101026
CCT251236PROTAC Ligand -
HY-13468
KW-2478
Publications Citing Use of MedChemExpress (MCE) DDO-5936
More
Biologische Aktivität
Beschreibung
IC50 & Target
Hsp90-Cdc37 PPI[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
55.74 μM
Compound: 15b; DDO-5936, Fig 1, Cpd 8
|
Antiproliferative activity against human A549 cells measured after 72 hrs by CCK8 assay
Antiproliferative activity against human A549 cells measured after 72 hrs by CCK8 assay
|
[PMID: 31935086] |
| HCT-116 | IC50 |
10.24 μM
Compound: 15b; DDO-5936, Fig 1, Cpd 8
|
Antiproliferative activity against human HCT116 cells measured after 72 hrs by CCK8 assay
Antiproliferative activity against human HCT116 cells measured after 72 hrs by CCK8 assay
|
[PMID: 31935086] |
| L02 | IC50 |
>50 μM
Compound: 15b; DDO-5936, Fig 1, Cpd 8
|
Cytotoxicity against human L02 cells measured after 72 hrs by CCK8 assay
Cytotoxicity against human L02 cells measured after 72 hrs by CCK8 assay
|
[PMID: 31935086] |
In Vitro
In Vivo
DDO-5936 is well tolerated for the absence of serious weight loss. DDO-5936 high dose groups show that tumor cells in the xenografts decreased significantly. DDO-5936 shows limited oral efficiency[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mice[1]
-
Dosage:0~80 mg/kg
-
Administration:P.o.
-
Result:Showed a moderate effect at the high dose group.
Chemical Information
-
CAS. Nr. 2355377-13-6
-
Appearance Solid
-
Molecular Weight 495.59
-
Formel C25H29N5O4S
-
Color White to yellow
-
SMILES
O=C(CN(S(=O)(C1=C(C)C=C(C)C=C1C)=O)C2=CC=C(NC3=NC(N4CCCC4)=NC=C3)C=C2)O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
RSC Adv
Discovery of new Hsp90-Cdc37 protein-protein interaction inhibitors: in silico screening and optimization of anticancer activity. [Abstract]2024 Sep 5;14(39):28347-28375. PMID: 39239280
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 12.5 mg/mL (25.22 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1.25 mg/mL (2.52 mM); Clear solution
This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (278 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.0178 mL | 10.0890 mL | 20.1780 mL | 50.4449 mL |
| 5 mM | 0.4036 mL | 2.0178 mL | 4.0356 mL | 10.0890 mL | |
| 10 mM | 0.2018 mL | 1.0089 mL | 2.0178 mL | 5.0445 mL | |
| 15 mM | 0.1345 mL | 0.6726 mL | 1.3452 mL | 3.3630 mL | |
| 20 mM | 0.1009 mL | 0.5044 mL | 1.0089 mL | 2.5222 mL | |
| 25 mM | 0.0807 mL | 0.4036 mL | 0.8071 mL | 2.0178 mL |
DDO-5936 Related Classifications
HY-139301 Related Classifications
Powered by Bioz